PETQ - Earnings announcements

Generates Record Second Quarter 2024 Net Sales and Net IncomeRecord Adjusted EBITDA of $39.0 Million Exceeds Company's Second Quarter 2024 GuidancePetIQ and Bansk Group Sign Definitive Merger Agreement EAGLE, Idaho, Aug. 07, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. ("PetIQ" or the "Company") (NASDAQ:PETQ), a leading pet medication, product and wellness company, today reported financial results for the second quarter and six months ended June 30, 2024. Cord Christensen, PetIQ's Founder and CEO, commented, "We are very pleased to report another quarter of record financial results. The strength of PetIQ's brands fueled second quarter profitability that exceeded our expectati

EAGLE, Idaho, July 17, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. ("PetIQ" or the "Company") (NASDAQ:PETQ), a leading pet medication, health and wellness company, today announced it will report financial results for the second quarter and six months ended June 30, 2024, on Wednesday, August 7, 2024, after the market close. The Company will host a conference call with members of the executive management team to discuss these results. The conference call is scheduled to begin at 4:30 p.m. ET on Wednesday, August 7, 2024. To listen to the live call participants in North America may dial 833-816-1410 and international participants may dial 412-317-0503. In addition, the call will be broadcast live

Reports Record First Quarter 2024 Net Sales of $308.4 MillionAchieves Record First Quarter Net IncomeRecord Adjusted EBITDA Exceeds Company's First Quarter 2024 GuidanceRaises Full Year 2024 Outlook EAGLE, Idaho, May 08, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. ("PetIQ" or the "Company") (NASDAQ:PETQ), a leading pet medication, product and wellness company, today reported financial results for the first quarter ended March 31, 2024. Cord Christensen, PetIQ's Founder and CEO commented, "We've started 2024 off well with broad-based growth and strong pet parent demand for our product offerings. PetIQ's manufactured brands captured a disproportionate amount of their category market share to fuel

EAGLE, Idaho, April 22, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. ("PetIQ" or the "Company") (NASDAQ:PETQ), a leading pet medication, health and wellness company, today announced it will report financial results for the first quarter ended March 31, 2024, on Wednesday, May 8, 2024, after the market close. The Company will host a conference call with members of the executive management team to discuss these results. The conference call is scheduled to begin at 4:30 p.m. ET on Wednesday, May 8, 2024. To participate on the live call listeners in North America may dial 833-816-1410 and international listeners may dial 412-317-0503. In addition, the call will be broadcast live over the Internet ho

Record Full Year 2023 Net Sales Increase 19.6% Year-Over-Year to Over $1.1 BillionAdjusted EBITDA Exceeds Company's Full Year 2023 GuidanceReports Highest Annual Cash from Operations in the Company's History of $61.9 MillionProvides First Quarter 2024 and Full Year 2024 Outlook EAGLE, Idaho, Feb. 28, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. ("PetIQ" or the "Company") (NASDAQ:PETQ), a leading pet medication, product and wellness company, today reported financial results for the fourth quarter and full year ended December 31, 2023. Cord Christensen, PetIQ's Founder and CEO commented, "2023 was a record year for PetIQ. I am very proud of our team's execution to grow our business, enabling u

EAGLE, Idaho, Feb. 07, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. ("PetIQ" or the "Company") (NASDAQ:PETQ), a leading pet medication and wellness company, today announced it will report financial results for the fourth quarter and full year ended December 31, 2023, on Wednesday, February 28, 2024, after the market close. The Company will host a conference call with members of the executive management team to discuss these results. The conference call is scheduled to begin at 4:30 p.m. ET on Wednesday, February 28, 2024. To participate on the live call listeners in North America may dial 833-816-1410 and international listeners may dial 412-317-0503. In addition, the call will be broadcast live

Record Third Quarter 2023 Net Sales Increase 32% to $277.0 Million Net Sales and Adjusted EBITDA Exceed Company's Third Quarter 2023 Guidance Highest Year-to-Date Cash from Operations in the Company's History of $64.7 Million Announces Services Segment Optimization Raises 2023 Annual Outlook EAGLE, Idaho, Nov. 07, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. ("PetIQ" or the "Company") (NASDAQ:PETQ), a leading pet medication and wellness company, today reported financial results for the third quarter and nine months ended September 30, 2023. Cord Christensen, PetIQ's Chairman & CEO commented, "We are pleased to report the highest third quarter financial results in the history of the Company.

EAGLE, Idaho, Oct. 17, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. ("PetIQ" or the "Company") (NASDAQ:PETQ), a leading pet medication and wellness company, today announced it will report financial results for the third quarter ended September 30, 2023, on Tuesday, November 7, 2023, after the market close. The Company will host a conference call with members of the executive management team to discuss these results. The conference call is scheduled to begin at 4:30 p.m. ET on Tuesday, November 7, 2023. To participate on the live call listeners in North America may dial 833-816-1410 and international listeners may dial 412-317-0503. In addition, the call will be broadcast live over the Internet h

Record Second Quarter 2023 Net Sales Increase 25% to $314.5 Million Net Sales and Adjusted EBITDA Exceeds Company's Second Quarter 2023 Guidance Record Second Quarter Cash from Operations of $57.7 Million Raises 2023 Annual Outlook EAGLE, Idaho, Aug. 08, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. ("PetIQ" or the "Company") (NASDAQ:PETQ), a leading pet medication and wellness company, today reported financial results for the second quarter and six months ended June 30, 2023. Cord Christensen, PetIQ's Chairman & CEO commented, "We are pleased to continue the year with second-quarter sales and adjusted EBITDA significantly exceeding our guidance. The strategic investments to drive awareness and

EAGLE, Idaho, July 20, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. ("PetIQ" or the "Company") (NASDAQ:PETQ), a leading pet medication and wellness company, today announced it will report financial results for the second quarter ended June 30, 2023, on Tuesday, August 8, 2023, after the market close. The Company will host a conference call with members of the executive management team to discuss these results. The conference call is scheduled to begin at 4:30 p.m. ET on Tuesday, August 8, 2023. To participate on the live call listeners in North America may dial 833-816-1410 and international listeners may dial 412-317-0503. In addition, the call will be broadcast live over the Internet hosted at

Reports First Quarter 2023 Net Sales of $290.5 MillionAchieves Record Quarterly Net IncomeRecord Quarterly Adjusted EBITDA Exceeds Company's First Quarter 2023 GuidanceReiterates 2023 Annual Outlook EAGLE, Idaho, May 09, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. ("PetIQ" or the "Company") (NASDAQ:PETQ), a leading pet medication and wellness company, today reported financial results for the first quarter ended March 31, 2023. Cord Christensen, PetIQ's Chairman & CEO commented, "We are very pleased with our first quarter results. The resilience of the pet health and wellness category and our brands is evident in our ability to exceed our first quarter net sales and profit expectations. The Comp

EAGLE, Idaho, April 18, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. ("PetIQ" or the "Company") (NASDAQ:PETQ), a leading pet medication and wellness company, today announced it will report financial results for the first quarter ended March 31, 2023, on Tuesday, May 9, 2023, after the market close. The Company will host a conference call with members of the executive management team to discuss these results. The conference call is scheduled to begin at 4:30 p.m. ET on Tuesday, May 9, 2023. To participate on the live call listeners in North America may dial 844-826-3033 and international listeners may dial 412-317-5185. In addition, the call will be broadcast live over the Internet hosted at the

Full Year 2022 Net Sales and Adjusted EBITDA In-Line with Company GuidanceUpdates Adjusted EBITDA MethodologyReports Record Annual Cash from Operations of $48.0 MillionCompletes Complementary, Margin Accretive Acquisition of Rocco & Roxie Provides First Quarter 2023 and Full Year 2023 Outlook EAGLE, Idaho, Feb. 28, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. ("PetIQ" or the "Company") (NASDAQ:PETQ), a leading pet medication and wellness company, today reported financial results for the fourth quarter and full year ended December 31, 2022. Cord Christensen, PetIQ's Chairman & CEO, commented, "We are pleased to report net sales and adjusted EBITDA in-line with our 2022 full year guidance as well

EAGLE, Idaho, Jan. 31, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. ("PetIQ" or the "Company") (NASDAQ:PETQ), a leading pet medication and wellness company, today announced it will report financial results for the fourth quarter and full year ended December 31, 2022, on Tuesday, February 28, 2023, after the market close. The Company will host a conference call with members of the executive management team to discuss these results. The conference call is scheduled to begin at 4:30 p.m. ET on Tuesday, February 28, 2023. To participate on the live call listeners in North America may dial 844-826-3033 and international listeners may dial 412-317-5185. In addition, the call will be broadcast live ove

Third Quarter 2022 Net Sales of Approximately $210 Million at the High-End of Guidance Adjusted EBITDA Exceeds Company's Third Quarter Guidance Reports Record Quarterly Cash from Operations of $64.5 Million Raises 2022 Annual Adjusted EBITDA Outlook EAGLE, Idaho, Nov. 09, 2022 (GLOBE NEWSWIRE) -- PetIQ, Inc. ("PetIQ" or the "Company") (NASDAQ:PETQ), a leading pet medication and wellness company, today reported financial results for the third quarter and nine months ended September 30, 2022. Cord Christensen, PetIQ's Chairman & CEO commented, "We are very pleased with our third quarter results. Our team delivered net sales at the high-end of our guidance range for the quarter and we sign

EAGLE, Idaho, Oct. 19, 2022 (GLOBE NEWSWIRE) -- PetIQ, Inc. ("PetIQ" or the "Company") (NASDAQ:PETQ), a leading pet medication and wellness company, today announced it will report financial results for the third quarter ended September 30, 2022, on Wednesday, November 9, 2022, after the market close. The Company will host a conference call with members of the executive management team to discuss these results with additional comments and details. The conference call is scheduled to begin at 4:30 p.m. ET on Wednesday, November 9, 2022. To participate on the live call listeners in North America may dial 844-826-3033 and international listeners may dial 412-317-5185. In addition, the call w

Second Quarter 2022 Net Income Increased 16.0% to $4.7 MillionReports Adjusted EBITDA of Approximately $28 MillionProvides Third Quarter 2022 Guidance and Updates 2022 Annual Outlook EAGLE, Idaho, Aug. 09, 2022 (GLOBE NEWSWIRE) -- PetIQ, Inc. ("PetIQ" or the "Company") (NASDAQ:PETQ), a leading pet medication and wellness company, today reported financial results for the second quarter and six months ended June 30, 2022. Cord Christensen, PetIQ's Chairman & CEO commented, "Consumption of our products by pet parents improved as we progressed through the second quarter with strong contribution from PetIQ's higher-margin manufactured produc

EAGLE, Idaho, July 19, 2022 (GLOBE NEWSWIRE) -- PetIQ, Inc. ("PetIQ" or the "Company") (NASDAQ:PETQ), a leading pet medication and wellness company, today announced it will report financial results for the second quarter ended June 30, 2022, on Tuesday, August 9, 2022, after the market close. The Company will host a conference call with members of the executive management team to discuss these results with additional comments and details. The conference call is scheduled to begin at 4:30 p.m. ET on Tuesday, August 9, 2022. To participate on the live call listeners in North America may dial 866-652-5200 and international listeners may dial 412-317-6060. In addition, the call will be broad

Reports First Quarter Net Sales of $275.7 Million Company Provides Second Quarter 2022 Guidance and Reiterates Full Year 2022 Outlook EAGLE, Idaho, May 04, 2022 (GLOBE NEWSWIRE) -- PetIQ, Inc. ("PetIQ" or the "Company") (NASDAQ:PETQ), a leading pet medication and wellness company, today reported financial results for the first quarter ended March 31, 2022. Cord Christensen, PetIQ's Chairman & CEO commented, "We started 2022 off strong. Our first quarter financial results exceeded our guidance driven by both our Products and Services segments. We benefitted from higher-than-normal fill rates at our retail and e-commerce partners in preparation for the flea and tick season, new product

EAGLE, Idaho, April 13, 2022 (GLOBE NEWSWIRE) -- PetIQ, Inc. ("PetIQ" or the "Company") (NASDAQ:PETQ), a leading pet medication and wellness company, today announced it will report financial results for the first quarter ended March 31, 2022, on Wednesday, May 4, 2022, after the market close. The Company will host a conference call with members of the executive management team to discuss these results with additional comments and details. The conference call is scheduled to begin at 4:30 p.m. ET on Wednesday, May 4, 2022. To participate on the live call listeners in North America may dial 877-451-6152 and international listeners may dial 201-389-0879. In addition, the call will be broadc

Reports Fourth Quarter Net Sales of $196.6 Million and Full Year Net Sales of $932.5 Million Company Provides First Quarter 2022 and Full Year 2022 Outlook EAGLE, Idaho, March 01, 2022 (GLOBE NEWSWIRE) -- PetIQ, Inc. ("PetIQ" or the "Company") (NASDAQ:PETQ), a leading pet medication and wellness company, today reported financial results for the fourth quarter and full year ended December 31, 2021. Cord Christensen, PetIQ's Chairman & CEO commented, "We are very pleased with our strong finish to 2021. Our record fourth quarter was better than we expected driven by growth in the Products segment as we benefited from strong flea and tick and health and wellness sales." Chr

EAGLE, Idaho, Feb. 08, 2022 (GLOBE NEWSWIRE) -- PetIQ, Inc. ("PetIQ" or the "Company") (NASDAQ:PETQ), a leading pet medication and wellness company, today announced it will report results for the fourth quarter and full year ended December 31, 2021, on Tuesday, March 1, 2022, after the market close. The Company will host a conference call with members of the executive management team to discuss these results with additional comments and details. The conference call is scheduled to begin at 4:30 p.m. ET on Tuesday, March 1, 2022. To participate on the live call listeners in North America may dial 877-451-6152 and international listeners may dial 201-389-0879. In addition, the call will be

EAGLE, Idaho, Nov. 03, 2021 (GLOBE NEWSWIRE) -- PetIQ, Inc. ("PetIQ" or the "Company") (NASDAQ:PETQ), a leading pet medication and wellness company, today reported financial results for the third quarter and nine months ended September 30, 2021. Cord Christensen, PetIQ's Chairman & CEO commented, "We are very pleased with our record third quarter results. The Product segment returned to a more normal sales cadence, and we increased market share on our core manufactured items for the third consecutive quarter this year, helping to fuel the Company's profitability. Our net sales growth was led by the e-commerce sales channel with an increase of 51% year-over-year and strong contribution f

EAGLE, Idaho, Oct. 20, 2021 (GLOBE NEWSWIRE) -- PetIQ, Inc. ("PetIQ" or the "Company") (NASDAQ:PETQ), a leading pet medication and wellness company, today announced it will report results for the third quarter ended September 30, 2021, on Wednesday, November 3, 2021, after the market close. The Company will host a conference call with members of the executive management team to discuss these results with additional comments and details. The conference call is scheduled to begin at 4:30 p.m. ET on Wednesday, November 3, 2021. To participate on the live call listeners in North America may dial 877-451-6152 and international listeners may dial 201-389-0879. In addition, the call will be bro

EAGLE, Idaho, Aug. 04, 2021 (GLOBE NEWSWIRE) -- PetIQ, Inc. ("PetIQ" or the "Company") (NASDAQ:PETQ), a leading pet medication and wellness company, today reported financial results for the second quarter and six months ended June 30, 2021. Cord Christensen, PetIQ's Chairman & CEO commented, "We are pleased with our ability to report record second quarter results that demonstrate the benefit from our evolving sales mix towards higher margin products. It was our highest net sales quarter, the best gross profit dollar and gross margin quarter as well as our highest adjusted EBITDA quarter in the history of the company. We accomplished this even as we continue to operate in a unique environm

EAGLE, Idaho, July 22, 2021 (GLOBE NEWSWIRE) -- PetIQ, Inc. ("PetIQ" or the "Company") (NASDAQ:PETQ), a leading pet medication and wellness company, today announced it will report results for the second quarter ended June 30, 2021, on Wednesday, August 4, 2021, after the market close. The Company will host a conference call with members of the executive management team to discuss these results with additional comments and details. The conference call is scheduled to begin at 4:30 p.m. ET on Wednesday, August 4, 2021. To participate on the live call, listeners in North America may dial 877-451-6152 and international listeners may dial 201-389-0879. In addition, the call will be broadcast